More specifically, MALAT1, expressed at high levels in the MSCs from myeloma patients, was shown to recruit the transcription factor SP1 on the LTBP3 promoter contributing to the increase of LTBP3 expression, most likely by stabilizing the interaction between SP1 and SP1-consensus sequences. This evidence concerns the gene SP1 and plasma cell myeloma.